Non Small Cell Lung Cancer Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
XOMA | A | XOMA Corporation | 0.20 | |
CGEM | A | Cullinan Management, Inc. | 31.22 | |
HCM | A | Hutchison China MediTech Limited | -5.19 | |
CRIS | B | Curis, Inc. | 1.17 | |
ACHV | B | Achieve Life Sciences, Inc. | 1.09 | |
LYEL | C | Lyell Immunopharma, Inc. | -1.36 | |
OPK | C | OPKO Health Inc. | 2.87 | |
EVAX | D | Evaxion Biotech A/S | -1.70 | |
ADAP | D | Adaptimmune Therapeutics plc | 1.89 | |
TIL | D | Instil Bio, Inc. | 1.92 |
Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
Related Stock Lists:
Cancer
Small Cell Lung Cancer
Medicine
Solid Tumors
Biopharmaceutical
Cancer Immunotherapy
Clinical Medicine
Melanoma
Multiple Myeloma
Prostate Cancer
Antibodies
Biotechnology
Breast Cancer
Cell Therapy
Clinical Trial
Drug Discovery
Hematological Cancers
Immune System
Immunology
Immunotherapy
Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.66 | |
CNCR | D | Loncar Cancer Immunotherapy ETF | 1.3 | |
FORH | B | Formidable ETF | 1.15 | |
XBI | D | SPDR S&P Biotech ETF | 0.91 | |
INNO | D | Harbor Disruptive Innovation ETF | 0.87 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Major
Drug Manufacturers - Specialty & Generic
Long-Term Care Facilities
Medical Instruments & Supplies
Related Stock Lists:
Cancer
Biopharmaceutical
Clinical Medicine
Small Cell Lung Cancer
Solid Tumors
Medicine
Melanoma
Cancer Immunotherapy
Drugs
Lung Cancer
Multiple Myeloma
NSCLC
Acute Myeloid Leukemia
Antineoplastic Drugs
Breast Cancer
Cancer Treatment
Carcinoma
Hematological Malignancies
Immunotherapy
Non Small Cell Lung Carcinoma
- Non Small Cell Lung Cancer
Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles